Invicta Diagnostic Limited (NSE:INVICTA)
74.75
-2.25 (-2.92%)
At close: Nov 20, 2026
Invicta Diagnostic Revenue
Invicta Diagnostic had revenue of 123.76M INR in the quarter ending September 30, 2026, with 44.92% growth. This brings the company's total for the last twelve months to 407.15M. In the fiscal year ending March 31, 2026, Invicta Diagnostic had annual revenue of 330.42M with 9.48% growth. That makes Invicta Diagnostic the 40,439th largest company in the world by revenue and 3,957th in India.
Revenue (ttm)
407.15M
Revenue Growth
+9.48%
P/S Ratio
2.31
Revenue / Employee
3.11M
Employees
131
Market Cap
939.75M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 330.42M | 28.61M | 9.48% |
| Mar 31, 2025 | 301.81M | 142.83M | 89.84% |
| Mar 31, 2024 | 158.98M | 90.55M | 132.33% |
| Mar 31, 2023 | 68.43M | 39.40M | 135.74% |
| Mar 31, 2022 | 29.03M | - | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Thyrocare Technologies | 9.30B |
| One Global Service Provider | 4.45B |
| Chandan Healthcare | 2.94B |
| Star Imaging and Path Lab | 921.87M |
| Modern Diagnostic & Research Centre | 841.50M |
| Pramodini Medicare | 622.88M |
| Aspira Pathlab & Diagnostics | 240.71M |
| Clinitech Laboratory | 137.53M |